José Luis Pérez

Mechanisms leading to in vivo ceftolozane/tazobactam resistance development during the treatment of infections caused by MDR Pseudomonas aeruginosa

Pablo A. Fraile-Ribot, Gabriel Cabot, Xavier Mulet et al. · Journal of Antimicrobial Chemotherapy · 2017 · 203 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Molecular Epidemiology and Mechanisms of Carbapenem Resistance in <i>Pseudomonas aeruginosa</i> Isolates from Spanish Hospitals

Olivia Gutiérrez, Carlos Juan, Emilia Cercenado et al. · Antimicrobial Agents and Chemotherapy · 2007 · 184 citations

Life Sciences, Infectious Diseases, Microbiology +17

Molecular Mechanisms of β-Lactam Resistance Mediated by AmpC Hyperproduction in<i>Pseudomonas aeruginosa</i>Clinical Strains

Carlos Juan, María D. Macià, Olivia Gutiérrez et al. · Antimicrobial Agents and Chemotherapy · 2005 · 170 citations · Full text

Life Sciences, Microbiology, Molecular Biology +17

Stepwise Upregulation of the<i>Pseudomonas aeruginosa</i>Chromosomal Cephalosporinase Conferring High-Level β-Lactam Resistance Involves Three AmpD Homologues

Carlos Juan, Bartolomé Moyá, José Luis Pérez et al. · Antimicrobial Agents and Chemotherapy · 2006 · 165 citations · Full text

Life Sciences, Microbiology, Molecular Biology +17

Characterization of a Large Outbreak by CTX-M-1-Producing <i>Klebsiella pneumoniae</i> and Mechanisms Leading to In Vivo Carbapenem Resistance Development

A. Mena, Virginia Plasencia, Laura Molina García et al. · Journal of Clinical Microbiology · 2006 · 144 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17